161 related articles for article (PubMed ID: 34103994)
1. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p.
Han X; Liu J; Liu Y; Mou L; Li C
Cancer Manag Res; 2021; 13():4393-4401. PubMed ID: 34103994
[TBL] [Abstract][Full Text] [Related]
2. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
Hao T; Huang S; Han F
Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
[TBL] [Abstract][Full Text] [Related]
3. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p].
Yang H; Cao C; Wang LJ
Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):325-330. PubMed ID: 32375449
[No Abstract] [Full Text] [Related]
4. Long noncoding RNA LINC-PINT retards the abnormal growth of airway smooth muscle cells via regulating the microRNA-26a-5p/PTEN axis in asthma.
Gao P; Ding Y; Yin B; Gu H
Int Immunopharmacol; 2021 Oct; 99():107997. PubMed ID: 34315115
[TBL] [Abstract][Full Text] [Related]
5. LINC-PINT suppresses breast cancer cell proliferation and migration via MEIS2/PPP3CC/NF-κB pathway by sponging miR-576-5p.
Li D; Hu A
Am J Med Sci; 2024 Mar; 367(3):201-211. PubMed ID: 37660994
[TBL] [Abstract][Full Text] [Related]
6. LINC-PINT Suppresses the Aggressiveness of Thyroid Cancer by Downregulating miR-767-5p to Induce TET2 Expression.
Jia M; Li Z; Pan M; Tao M; Wang J; Lu X
Mol Ther Nucleic Acids; 2020 Dec; 22():319-328. PubMed ID: 33230437
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4.
Zhang L; Hu J; Li J; Yang Q; Hao M; Bu L
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1595-1602. PubMed ID: 31010333
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LINC-PINT increases SOCS1 expression by sponging miR-155-5p to inhibit the activation of ERK signaling pathway in rheumatoid arthritis synovial fibroblasts induced by TNF-α.
Wang J; Zhao Q
Int Immunopharmacol; 2020 Jul; 84():106497. PubMed ID: 32289665
[TBL] [Abstract][Full Text] [Related]
9. Linc-PINT acted as a tumor suppressor by sponging miR-543 and miR-576-5p in esophageal cancer.
Zhang L; Chen J; Wang L; Chen L; Du Z; Zhu L; Cui M; Zhang M; Song L
J Cell Biochem; 2019 Dec; 120(12):19345-19357. PubMed ID: 31464068
[TBL] [Abstract][Full Text] [Related]
10. LncRNA AGAP2-AS1 Promotes Cancer Cell Proliferation, Migration and Invasion in Colon Cancer by Forming a Negative Feedback Loop with LINC-PINT.
Ji L; Chen S; Gu L; Wang J; Zhang X
Cancer Manag Res; 2021; 13():2153-2161. PubMed ID: 33688258
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival.
Feng H; Zhang J; Shi Y; Wang L; Zhang C; Wu L
J Cell Biochem; 2019 Jun; 120(6):9594-9600. PubMed ID: 30569513
[TBL] [Abstract][Full Text] [Related]
12. MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells
Zhang S; Wang Q; Li W; Chen J
Front Mol Biosci; 2021; 8():793493. PubMed ID: 35127818
[No Abstract] [Full Text] [Related]
13. LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1).
Zhou X; Wang Y; Li Q; Ma D; Nie A; Shen X
Biochem Biophys Res Commun; 2020 Sep; 530(1):47-53. PubMed ID: 32828314
[TBL] [Abstract][Full Text] [Related]
14. LINC-PINT alleviates lung cancer progression via sponging miR-543 and inducing PTEN.
Wang S; Jiang W; Zhang X; Lu Z; Geng Q; Wang W; Li N; Cai X
Cancer Med; 2020 Mar; 9(6):1999-2009. PubMed ID: 31981466
[TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressor microRNA-139-5p restrains bladder cancer cell line ECV-304 properties via targeting Connexin 43.
Chi Q; Wang ZY; Li HY; Song DB; Xu H; Ma G; Wang ZM; Li XM
Chin Med J (Engl); 2019 Oct; 132(19):2354-2361. PubMed ID: 31567382
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis.
Yuan Z; Xiu C; Liu D; Zhou G; Yang H; Pei R; Ding C; Cui X; Sun J; Song K
J Cell Physiol; 2019 Dec; 234(12):23111-23122. PubMed ID: 31131448
[TBL] [Abstract][Full Text] [Related]
17. LncRNA LINC-PINT Inhibits Cancer Cell Proliferation, Invasion, and Migration in Osteosarcoma by Downregulating miRNA-21.
Liu W
Cancer Biother Radiopharm; 2019 May; 34(4):258-263. PubMed ID: 31070482
[No Abstract] [Full Text] [Related]
18. Downregulation of lncRNA LINC-PINT Participates in the Recurrence of Esophageal Squamous Cell Carcinoma Possibly by Interacting miRNA-21.
Rong H; Chen B; Ma K; Wei X; Peng J; Zhu J
Cancer Biother Radiopharm; 2021 Apr; 36(3):273-279. PubMed ID: 32401035
[No Abstract] [Full Text] [Related]
19. LncRNA RNF144A-AS1 Promotes Bladder Cancer Progression via RNF144A-AS1/miR-455-5p/SOX11 Axis.
Bi H; Shang Z; Jia C; Wu J; Cui B; Wang Q; Ou T
Onco Targets Ther; 2020; 13():11277-11288. PubMed ID: 33177836
[TBL] [Abstract][Full Text] [Related]
20. CircPRKCI regulates proliferation, migration and cycle of lung adenocarcinoma cells by targeting miR-219a-5p-regulated CAMK1D.
Sui MH; Zhang WW; Geng DM; Sun DJ
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1899-1909. PubMed ID: 33660800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
